BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts

Background: Inherited mutations in the tumour suppressor gene BRCA2 greatly increase the risk of developing breast, ovarian and other types of cancers. So far, most studies have focused on the role of BRCA-pathways in the maintenance of genomic stability.

Saved in:
Bibliographic Details
Main Authors: Asta Björk Jonsdottir, Maaike P. G. Vreeswijk, Ron Wolterbeek, Peter Devilee, Hans J. Tanke, Jorunn E. Eyfjörd, Karoly Szuhai
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0465
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548384188137472
author Asta Björk Jonsdottir
Maaike P. G. Vreeswijk
Ron Wolterbeek
Peter Devilee
Hans J. Tanke
Jorunn E. Eyfjörd
Karoly Szuhai
author_facet Asta Björk Jonsdottir
Maaike P. G. Vreeswijk
Ron Wolterbeek
Peter Devilee
Hans J. Tanke
Jorunn E. Eyfjörd
Karoly Szuhai
author_sort Asta Björk Jonsdottir
collection DOAJ
description Background: Inherited mutations in the tumour suppressor gene BRCA2 greatly increase the risk of developing breast, ovarian and other types of cancers. So far, most studies have focused on the role of BRCA-pathways in the maintenance of genomic stability.
format Article
id doaj-art-24655bd323a648ac8b0d4fef70a3706f
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-24655bd323a648ac8b0d4fef70a3706f2025-02-03T06:14:11ZengWileyCellular Oncology1570-58701875-86062009-01-0131319120110.3233/CLO-2009-0465BRCA2 Heterozygosity Delays Cytokinesis in Primary Human FibroblastsAsta Björk Jonsdottir0Maaike P. G. Vreeswijk1Ron Wolterbeek2Peter Devilee3Hans J. Tanke4Jorunn E. Eyfjörd5Karoly Szuhai6Faculty of Medicine, University of Iceland, Reykjavik, IcelandDepartment of Human Genetics, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Medical Statistics, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Human Genetics, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Molecular Cell Biology, Leiden University Medical Center, Leiden, The NetherlandsFaculty of Medicine, University of Iceland, Reykjavik, IcelandDepartment of Molecular Cell Biology, Leiden University Medical Center, Leiden, The NetherlandsBackground: Inherited mutations in the tumour suppressor gene BRCA2 greatly increase the risk of developing breast, ovarian and other types of cancers. So far, most studies have focused on the role of BRCA-pathways in the maintenance of genomic stability.http://dx.doi.org/10.3233/CLO-2009-0465
spellingShingle Asta Björk Jonsdottir
Maaike P. G. Vreeswijk
Ron Wolterbeek
Peter Devilee
Hans J. Tanke
Jorunn E. Eyfjörd
Karoly Szuhai
BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
Cellular Oncology
title BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
title_full BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
title_fullStr BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
title_full_unstemmed BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
title_short BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
title_sort brca2 heterozygosity delays cytokinesis in primary human fibroblasts
url http://dx.doi.org/10.3233/CLO-2009-0465
work_keys_str_mv AT astabjorkjonsdottir brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts
AT maaikepgvreeswijk brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts
AT ronwolterbeek brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts
AT peterdevilee brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts
AT hansjtanke brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts
AT jorunneeyfjord brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts
AT karolyszuhai brca2heterozygositydelayscytokinesisinprimaryhumanfibroblasts